Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
Business Wire India The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase…